Gold - ICPMS

Gold - ICPMS is a specialized diagnostic biochemical test designed to measure the concentration of gold using advanced Inductively Coupled Plasma Mass Spectrometry (ICP-MS technology). While gold is rarely encountered in toxic quantities, measuring trace gold levels is essential for patients undergoing chrysotherapy (gold compound treatments for rheumatoid arthritis), individuals exposed to occupational hazards, or those investigated for heavy metal toxicity.

Measurement of trace metals via ICP-MS provides direct clinical insight into elemental exposure and systemic toxicity. Because early identification of heavy metal accumulation supports timely therapeutic and clinical intervention, specialized biochemical testing supplies essential clinical data for toxicology, rheumatology, occupational medicine, and internal medicine evaluations.

The test requires an appropriate biological specimen collected by a qualified person using trace-element free containers, followed by precise analysis using state-of-the-art ICP-MS instrumentation. Results must always be interpreted in conjunction with the patient's clinical presentation, occupational history, and medication records.

Benefits of Gold - ICPMS Testing

• Provides a highly sensitive quantitative measurement of trace gold levels using ICP-MS.
• Helps monitor patients receiving gold-based pharmacological treatments (chrysotherapy).
• Assists clinicians in toxicology and occupational medicine evaluations.
• Aids in identifying rare heavy metal exposure or toxicity risks.
• Supports tracking of specialized therapeutic and clinical care plans.
• Complements comprehensive heavy metal panels, kidney function tests, and complete blood counts.
• Utilizes precise laboratory mass spectrometry techniques for reliable results.
• Assists specialists in determining appropriate medical and management strategies.
• Provides dependable turnaround times to support specialized clinical care.
• Utilizes standard trace-element free specimen collection procedures under medical supervision.

Clinical Indications and Applications

Toxicology Screening: The primary clinical indication is evaluating patients undergoing gold salt therapy for autoimmune conditions, or investigating suspected occupational exposure to heavy metals.

Clinical Assessment: The test is utilized when screening for elemental concentrations in specialized clinical or toxicology settings.

Why Doctors Recommend This Test

Toxicologists, rheumatologists, occupational health physicians, and internal medicine specialists recommend this test when monitoring therapeutic gold levels or investigating unusual heavy metal toxicity. It delivers essential quantitative data required to guide safe clinical intervention.

Following proper specimen collection guidelines will ensure a smooth and efficient testing procedure.

What Happens During The Procedure?

The collection procedure involves obtaining an appropriate biological specimen drawn by a qualified phlebotomist using specialized trace-element free collection containers provided by the facility under appropriate supervision protocols.

Once obtained, the sample is tested in the laboratory using advanced ICP-MS analyzers to quantify gold concentrations. The procedure takes only a few minutes.

Normal Reporting Time

The report for the Gold - ICPMS test is generally available within 24 to 48 hours due to standard laboratory processing times. Results must be reviewed promptly with the referring physician or specialist.

Who Should Consider This Test?

• Patients undergoing chrysotherapy or gold compound treatments for rheumatoid arthritis.
• Individuals investigated for occupational exposure or rare heavy metal toxicity as directed by a clinician.

Understanding Test Results

Test results provide quantitative concentrations of gold, evaluated against established laboratory reference ranges.

Normal Findings: Normal results indicate baseline trace levels or expected therapeutic concentrations depending on medication history.

Abnormal Findings: Elevated gold levels suggest excessive accumulation or toxicity, requiring prompt clinical evaluation and management adjustment.

Clinical Limitations

ICP-MS trace metal assays require strict prevention of sample contamination; results must be correlated with the patient's full clinical and occupational history.

Important Safety Information

Severe toxicological symptoms or acute adverse drug reactions require immediate emergency medical attention. Patients must consult their healthcare provider or specialist to interpret heavy metal screening findings.